AwesomeCapital
Search This Blog
Tuesday, August 13, 2019
NextCure target upped to $33 from $25 by Morgan Stanley
Maintains Overweight
https://www.benzinga.com/stock/NXTC/ratings
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.